BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27659160)

  • 1. Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (-)-N-Methylephedrine.
    Tulashie SK; Polenske D; Seidel-Morgenstern A; Lorenz H
    J Pharm Sci; 2016 Nov; 105(11):3359-3365. PubMed ID: 27659160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
    Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
    J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online monitoring of preferential crystallization of enantiomers.
    Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
    Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
    Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
    J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical-Chemical Properties of the Chiral Fungicide Fenamidone and Strategies for Enantioselective Crystallization.
    Kort AK; Lorenz H; Seidel-Morgenstern A
    Chirality; 2016 Jun; 28(6):514-20. PubMed ID: 27225331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
    Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
    Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.
    Choobdari E; Fakhraian H; Peyrovi MH
    Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the phase diagrams of chiral praziquantel.
    Liu Y; Wang X; Wang JK; Ching CB
    Chirality; 2006 May; 18(4):259-64. PubMed ID: 16521119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical properties, binary and ternary phase diagrams of ketoprofen.
    Hong Lu Y; Bun Ching C
    Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalemic mixtures preparation for optimized composition of ibuprofen solid dosage forms.
    Corvis Y; Guiblin N; Négrier P; Marenco I; Dembélé O; Espeau P
    Eur J Pharm Biopharm; 2021 Dec; 169():91-96. PubMed ID: 34571192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
    Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
    Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
    Duddu SP; Grant DJ
    Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
    Wang XJ; Wiehler H; Ching CB
    Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of racemic felodipine and the unusual series of solid solutions in the binary system of its enantiomers.
    Rollinger JM; Burger A
    J Pharm Sci; 2001 Jul; 90(7):949-59. PubMed ID: 11458342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.
    Duddu SP; Grant DJ
    Pharm Res; 1994 Nov; 11(11):1549-56. PubMed ID: 7870670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
    Lorenz H; Polenske D; Seidel-Morgenstern A
    Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of direct crystallization for racemic compound propranolol hydrochloride.
    Wang X; Lu J; Ching CB
    J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.